Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lilly commences cash tender offer for ImClone Systems
Lilly and ImClone have previously announced that they had reached a definitive merger agreement for Lilly to acquire ImClone. There is no financing condition to the tender offer.
Lilly and ImClone have previously announced that they had reached a definitive merger agreement for Lilly to acquire ImClone. There is no financing condition to the tender offer.
The Blair-Port Wand is a critical component of the company’s patented and FDA-approved surgical sponge detection system. Prior to beginning closing procedures, a surgical patient is scanned with
Under the terms of the agreement, Coda will utilize its proprietary suite of technologies to create highly diverse and complex libraries of synthetic genes and proteins for Genencor.
For the past 15 years, Mr Hughes held senior management positions in Biomet, previously Interpore Cross, serving as vice president of Western US sales and international. Mr Hughes
Inter Medico will distribute several EraGen molecular tests that recently received Health Canada approval for marketing as in vitro diagnostics. The approved tests are performed on the company’s
Mr Nickolas will assume full operational responsibility of BioPharmetics, effective immediately. As president and CEO of BioPharmetics, Mr Nickolas will be responsible for using his knowledge and expertise
The parties have agreed to licensing and other terms and assurance of protection of disputed intellectual property. Remaining terms of the settlement agreement are confidential.
The objective of the Phase IIa study is to assess hemodynamic and renal effects of CD-NP in patients with acute heart failure. In this dose escalation trial, stabilized
Mr Lordeman joins OrthoMEMS after serving as the COO of the Cleveland Clinic Foundation and Health System. Previously, Mr Lordeman spent over 20 years in healthcare leadership positions
In each study, aplindore demonstrated highly significant efficacy and was well tolerated. Neurogen believes aplindore’s dopamine partial agonist controlled release profile may be better tolerated, with fewer side